|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.5 EUR | +4.17% |
|
-6.40% | +217.73% |
| Apr. 23 | SynBiotic Boosts CBD Business with Ilesol Pharmaceuticals Takeover | MT |
| Apr. 23 | SynBiotic SE acquired Ilesol Pharmaceuticals d.o.o. za proizvodnju i usluge. | CI |
SynBiotic SE reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 8.17 million compared to EUR 8.65 million a year ago. Net loss was EUR 24.36 million compared to EUR 12.72 million a year ago.
Basic loss per share from continuing operations was EUR 5.97 compared to EUR 4.15 a year ago. Diluted loss per share from continuing operations was EUR 5.97 compared to EUR 4.15 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +217.73% | 47.64M | |
| +56.08% | 3.73B | |
| +188.32% | 2.03B | |
| +144.44% | 59.76M |
SYNBIOTIC SE 
